This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to the VA Northern California Health Care System (VANCHCS). The contract has a ceiling value of $2,500,000 and a performance period through March 31, 2030.
Under this IDC, RLS (USA) Inc. will deliver radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and gallium-68 dotatate to support nuclear medicine diagnostic services at VA medical centers. The contract is not designated as a set-aside. A $378,281.55 delivery order was recently issued under the IDC with a performance period through March 31, 2026. RLS (USA) Inc. holds several other IDCs with the VA and Defense Health Agency for radiopharmaceutical supplies, ranging in value from hundreds of thousands to nearly $5 million.
Generated 1/1/25, 9:06 AM